» Articles » PMID: 15765103

NF-kappaB Plays a Major Role During the Systemic and Local Acute Inflammatory Response Following Intestinal Reperfusion Injury

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2005 Mar 15
PMID 15765103
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

1 The nuclear translocation of transcription factors may be a critical factor in the intracellular pathway involved in ischaemia/reperfusion (I/R) injury. Here, we examined whether NF-kappaB and AP-1 participated in the cascade of events leading to TNF-alpha production, neutrophil recruitment, tissue injury and lethality following intestinal I/R. 2 The superior mesenteric artery (SMA) of mice was made ischaemic for 60 min followed by 30 min of reperfusion. The effects of NF-kappaB and AP-1 were studied by the administration of the thioredoxin inhibitor, MOL-294 (methyl 4-hydroxy-4-(8-methyl-1,3-dioxo-2-phenyl-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl)but-2-ynoate), and the AP-1 inhibitor, PNRI-299 (N-benzyl-2-(3-cyanophenyl)-1,3,7-trioxo-2,3,7,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5-carboxamide). After I/R, there was increase of translocation of NF-kappaB, but not of AP-1, in the intestine and lungs, as assessed by a gel shift assay. 3 Treatment with MOL-294 inhibited the increase in vascular permeability, neutrophil accumulation, hemorrhage and proinflammatory cytokine levels, induced by intestinal I/R injury in the intestine. In the lungs, MOL-294 partially inhibited edema formation, TNF-alpha production, but did not alter neutrophil recruitment. 4 Treatment with MOL-294 inhibited reperfusion-associated lethality, an effect likely to be secondary to the inhibition of systemic TNF-alpha levels. PNRI-299 had no effects on the inflammatory changes or lethality induced by I/R injury. 5 Our results point to an important role for NF-kappaB in triggering endogenous proinflammatory networks during intestinal I/R injury. Inhibition of NF-kappaB prevents tissue injury and lethality, and this was associated with inhibition of TNF-alpha production and decrease in neutrophil recruitment.

Citing Articles

Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.

Dailah H Molecules. 2022; 27(17).

PMID: 36080309 PMC: 9458015. DOI: 10.3390/molecules27175542.


Role and Potential Mechanism of Heme Oxygenase-1 in Intestinal Ischemia-Reperfusion Injury.

Katada K, Takagi T, Iida T, Ueda T, Mizushima K, Fukui A Antioxidants (Basel). 2022; 11(3).

PMID: 35326209 PMC: 8945098. DOI: 10.3390/antiox11030559.


Protective effects of syringic acid on inflammation, apoptosis and intestinal barrier function in Caco-2 cells following oxygen-glucose deprivation/reoxygenation-induced injury.

Xiang S, Xiao J Exp Ther Med. 2021; 23(1):66.

PMID: 34934437 PMC: 8649867. DOI: 10.3892/etm.2021.10989.


mtDNA-STING pathway promotes necroptosis-dependent enterocyte injury in intestinal ischemia reperfusion.

Zhang X, Wu J, Liu Q, Li X, Li S, Chen J Cell Death Dis. 2020; 11(12):1050.

PMID: 33311495 PMC: 7732985. DOI: 10.1038/s41419-020-03239-6.


Progress in the mechanism and targeted drug therapy for COPD.

Wang C, Zhou J, Wang J, Li S, Fukunaga A, Yodoi J Signal Transduct Target Ther. 2020; 5(1):248.

PMID: 33110061 PMC: 7588592. DOI: 10.1038/s41392-020-00345-x.


References
1.
Zingarelli B, Sheehan M, Wong H . Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med. 2003; 31(1 Suppl):S105-11. DOI: 10.1097/00003246-200301001-00015. View

2.
Cornejo C, Winn R, Harlan J . Anti-adhesion therapy. Adv Pharmacol. 1997; 39:99-142. DOI: 10.1016/s1054-3589(08)60070-8. View

3.
Pye J, Ardeshirpour F, McCain A, Bellinger D, Merricks E, Adams J . Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol. 2002; 284(3):H919-26. DOI: 10.1152/ajpheart.00851.2002. View

4.
Zou L, Attuwaybi B, Kone B . Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2002; 284(4):G713-21. DOI: 10.1152/ajpgi.00431.2002. View

5.
Souza D, Guabiraba R, Pinho V, Bristow A, Poole S, Teixeira M . IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J Immunol. 2003; 170(9):4759-66. DOI: 10.4049/jimmunol.170.9.4759. View